ATE260640T1 - Osmotisches verabreichungssystem mit stöpselrückhaltemechanismus - Google Patents

Osmotisches verabreichungssystem mit stöpselrückhaltemechanismus

Info

Publication number
ATE260640T1
ATE260640T1 AT98963215T AT98963215T ATE260640T1 AT E260640 T1 ATE260640 T1 AT E260640T1 AT 98963215 T AT98963215 T AT 98963215T AT 98963215 T AT98963215 T AT 98963215T AT E260640 T1 ATE260640 T1 AT E260640T1
Authority
AT
Austria
Prior art keywords
retention mechanism
administration system
plug retention
osmotic administration
osmotic
Prior art date
Application number
AT98963215T
Other languages
English (en)
Inventor
Rupal Ayer
Original Assignee
Alza Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Alza Corp filed Critical Alza Corp
Application granted granted Critical
Publication of ATE260640T1 publication Critical patent/ATE260640T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0002—Galenical forms characterised by the drug release technique; Application systems commanded by energy
    • A61K9/0004—Osmotic delivery systems; Sustained release driven by osmosis, thermal energy or gas

Landscapes

  • Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Preparation (AREA)
  • Infusion, Injection, And Reservoir Apparatuses (AREA)
AT98963215T 1997-12-29 1998-12-15 Osmotisches verabreichungssystem mit stöpselrückhaltemechanismus ATE260640T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US6898797P 1997-12-29 1997-12-29
PCT/US1998/026654 WO1999033446A1 (en) 1997-12-29 1998-12-15 Osmotic delivery system with membrane plug retention mechanism

Publications (1)

Publication Number Publication Date
ATE260640T1 true ATE260640T1 (de) 2004-03-15

Family

ID=22085978

Family Applications (1)

Application Number Title Priority Date Filing Date
AT98963215T ATE260640T1 (de) 1997-12-29 1998-12-15 Osmotisches verabreichungssystem mit stöpselrückhaltemechanismus

Country Status (12)

Country Link
US (5) US6270787B1 (de)
EP (1) EP1041968B1 (de)
JP (1) JP4173635B2 (de)
AR (1) AR014194A1 (de)
AT (1) ATE260640T1 (de)
AU (1) AU1828599A (de)
CA (1) CA2316976C (de)
DE (1) DE69822208T2 (de)
ES (1) ES2217613T3 (de)
TW (1) TW446552B (de)
WO (1) WO1999033446A1 (de)
ZA (1) ZA9811880B (de)

Families Citing this family (105)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MY125870A (en) * 1997-07-25 2006-08-30 Alza Corp Osmotic delivery system flow modulator apparatus and method
JP4173635B2 (ja) * 1997-12-29 2008-10-29 インターシア セラピューティクス，インコーポレイティド 膜プラグ保持機構を有する浸透供給装置
DK1140014T3 (da) 1998-12-31 2003-07-14 Alza Corp Osmotisk afgivelsessystem med pladsbesparende stempel
US7258869B1 (en) 1999-02-08 2007-08-21 Alza Corporation Stable non-aqueous single phase viscous vehicles and formulations utilizing such vehicle
US7919109B2 (en) 1999-02-08 2011-04-05 Intarcia Therapeutics, Inc. Stable non-aqueous single phase viscous vehicles and formulations utilizing such vehicles
EP1328256B1 (de) * 1999-12-21 2005-10-19 Alza Corporation Ventil für osmotische vorrichtungen
US7163688B2 (en) * 2001-06-22 2007-01-16 Alza Corporation Osmotic implant with membrane and membrane retention means
US7927613B2 (en) * 2002-02-15 2011-04-19 University Of South Florida Pharmaceutical co-crystal compositions
US7790905B2 (en) * 2002-02-15 2010-09-07 Mcneil-Ppc, Inc. Pharmaceutical propylene glycol solvate compositions
WO2004000284A1 (en) * 2002-06-21 2003-12-31 Transform Pharmaceuticals, Inc. Pharmaceutical compositions with improved dissolution
WO2003074474A2 (en) * 2002-03-01 2003-09-12 University Of South Florida Multiple-component solid phases containing at least one active pharmaceutical ingredient
US20100311701A1 (en) * 2002-02-15 2010-12-09 Transform Pharmaceuticals, Inc Pharmaceutical Co-Crystal Compositions
NZ537136A (en) * 2002-06-17 2007-07-27 Alza Corp Osmotic delivery system with early zero order push power engine comprising an osmotic agent dispersed in the fluid vehicle
ATE376854T1 (de) 2002-06-26 2007-11-15 Alza Corp Minimal nachgiebiger volumen-effizienter kolben für osmotische medikamentenabgabesysteme
US7014636B2 (en) * 2002-11-21 2006-03-21 Alza Corporation Osmotic delivery device having a two-way valve and a dynamically self-adjusting flow channel
CA2508124A1 (en) * 2002-12-19 2004-07-08 Alza Corporation Stable, non-aqueous, single-phase gels and formulations thereof for delivery from an implantable device
US7731947B2 (en) * 2003-11-17 2010-06-08 Intarcia Therapeutics, Inc. Composition and dosage form comprising an interferon particle formulation and suspending vehicle
US8183290B2 (en) 2002-12-30 2012-05-22 Mcneil-Ppc, Inc. Pharmaceutically acceptable propylene glycol solvate of naproxen
EP2339328A3 (de) 2002-12-30 2011-07-13 Transform Pharmaceuticals, Inc. Pharmazeutische kokristallisierte Celecoxib-Zusammensetzungen
CA2513746C (en) 2003-02-28 2012-08-28 Transform Pharmaceuticals, Inc. Pharmaceutical co-crystal compositions of drugs such as carbamazeptine, celecoxib, olanzapine, itraconazole, topiramate, modafinil, 5-fluorouracil, hydrochlorothiazide, acetaminophen, aspirin, flurbiprofen, phenytoin and ibuprofen
NZ542867A (en) 2003-03-31 2009-02-28 Durect Corp Non-aqueous single phase vehicles and formulations utilizing such vehicles involving a polymer
CA2520766A1 (en) * 2003-03-31 2004-10-21 Alza Corporation Osmotic delivery system and method for decreasing start-up times for osmotic delivery systems
DE602004012081T2 (de) 2003-03-31 2009-03-19 Intarcia Therapeutics, Inc., Emeryville Osmotische pumpe mit mitteln zum ableiten des innendrucks
US20040214893A1 (en) * 2003-04-11 2004-10-28 Matthew Peterson Gabapentin compositions
US7186863B2 (en) 2003-05-23 2007-03-06 Transform Pharmaceuticals, Inc. Sertraline compositions
WO2005072079A2 (en) 2003-09-26 2005-08-11 Alza Coporation Drug coating providing high drug loading and methods for providing the same
US20070259033A1 (en) 2003-09-26 2007-11-08 Evangeline Cruz Controlled release formulations exhibiting an ascending rate of release
CA2540056C (en) * 2003-09-26 2015-03-24 Alza Corporation Controlled release formulations of opioid and nonopioid analgesics
ATE504288T1 (de) * 2003-09-26 2011-04-15 Alza Corp Oros-push-stick für die kontrollierte abgabe von wirkstoffen
WO2005032524A2 (en) * 2003-09-30 2005-04-14 Alza Corporation Osmotically driven active agent delivery device providing an ascending release profile
MXPA06002030A (es) * 2003-10-31 2006-05-17 Alza Corp Bomba osmotica con tapon de membrana de auto-retencion, de rapido inicio.
US20050113410A1 (en) * 2003-11-03 2005-05-26 Mark Tawa Pharmaceutical salts of zafirlukast
JP2007526792A (ja) * 2003-11-06 2007-09-20 アルザ・コーポレーシヨン 移植可能な浸透ポンプと一緒の使用のためのモジュール型の吸入速度低下器
AU2004293013B2 (en) 2003-11-19 2011-04-28 Metabasis Therapeutics, Inc. Novel phosphorus-containing thyromimetics
US20060004037A1 (en) * 2004-03-25 2006-01-05 Transform Pharmaceuticals, Inc. Novel tricyclic compounds and related methods of treatment
US20080022287A1 (en) * 2004-03-31 2008-01-24 Koninklijke Philips Electronics, N.V. Method And System For Transferring Budgets In A Technique For Restrained Budget Use
US20050266087A1 (en) * 2004-05-25 2005-12-01 Gunjan Junnarkar Formulations having increased stability during transition from hydrophobic vehicle to hydrophilic medium
EP1765379A4 (de) * 2004-06-17 2009-05-27 Transform Pharmaceuticals Inc Pharmazeutische ko-kristallzusammensetzungen und relevante anwendungsverfahren
EP1789128B1 (de) 2004-08-27 2018-05-09 STOCO 10 GmbH Elektronisch gesteuerte und ferngesteuerte tablette und system zur abgabe von mindestens einem medikament
US8541026B2 (en) * 2004-09-24 2013-09-24 Abbvie Inc. Sustained release formulations of opioid and nonopioid analgesics
US8779175B2 (en) 2004-10-25 2014-07-15 Synthonics, Inc. Coordination complexes, pharmaceutical solutions comprising coordination complexes, and methods of treating patients
US20060160783A1 (en) * 2004-12-30 2006-07-20 Transform Pharmaceuticals, Inc. Novel omeprazole forms and related methods
WO2006083761A2 (en) 2005-02-03 2006-08-10 Alza Corporation Solvent/polymer solutions as suspension vehicles
US7655254B2 (en) * 2005-02-03 2010-02-02 Intarcia Therapeutics, Inc. Implantable device for continuous delivery of interferon
US11246913B2 (en) 2005-02-03 2022-02-15 Intarcia Therapeutics, Inc. Suspension formulation comprising an insulinotropic peptide
US7959938B2 (en) 2005-03-15 2011-06-14 Intarcia Therapeutics, Inc. Polyoxaester suspending vehicles for use with implantable delivery systems
EP1906867A1 (de) * 2005-06-30 2008-04-09 Alza Corporation Osmotisches intraossäres arzneispendesystem
US20070027105A1 (en) * 2005-07-26 2007-02-01 Alza Corporation Peroxide removal from drug delivery vehicle
US7931620B2 (en) * 2006-02-01 2011-04-26 Roche Diagnostics International Ag Self-sealing connection for housing shells of an administering device
EP2015805A1 (de) * 2006-04-28 2009-01-21 Koninklijke Philips Electronics N.V. Osmotische pumpe mit mindestens einem aufladbaren material
AU2007266475B2 (en) 2006-05-30 2009-12-03 Intarcia Therapeutics, Inc. Two-piece, internal-channel osmotic delivery system flow modulator
JP5048773B2 (ja) 2006-08-09 2012-10-17 インターシア セラピューティクス，インコーポレイティド 浸透圧式デリバリーシステム及びピストンアセンブリー
US9114133B2 (en) 2006-08-25 2015-08-25 U.S. Dept. Of Veterans Affairs Method of improving diastolic dysfunction
US8617143B2 (en) * 2006-12-07 2013-12-31 The Regents Of The University Of California Therapeutic agent delivery systems and devices
CN101610995B (zh) 2007-02-09 2017-08-08 症变治疗公司 胰高血糖素受体拮抗剂
AU2008244523B2 (en) 2007-04-23 2012-02-16 Intarcia Therapeutics, Inc. Suspension formulations of insulinotropic peptides and uses thereof
AU2008282900B2 (en) * 2007-07-27 2014-05-22 Depomed, Inc. Pulsatile gastric retentive dosage forms
WO2009023718A2 (en) 2007-08-13 2009-02-19 Metabasis Therapeutics, Inc. Novel activators of glucokinase
US9226907B2 (en) 2008-02-01 2016-01-05 Abbvie Inc. Extended release hydrocodone acetaminophen and related methods and uses thereof
DK2240155T3 (da) 2008-02-13 2012-09-17 Intarcia Therapeutics Inc Indretninger, formuleringer og fremgangsmåder til levering af flere gavnlige midler
US8907103B2 (en) 2008-08-13 2014-12-09 Metabasis Therapeutics, Inc. Glucagon antagonists
AU2009303905B2 (en) * 2008-10-15 2015-01-22 Intarcia Therapeutics, Inc. Highly concentrated drug particles, formulations, suspensions and uses thereof
BRPI1006765A2 (pt) 2009-04-07 2019-03-26 Koninl Philips Electronics Nv cápsula ingerível para a liberação de uma droga
WO2011018753A1 (en) 2009-08-12 2011-02-17 Koninklijke Philips Electronics N.V. Drug delivery device with compressible drug reservoir
SMT201700583T1 (it) 2009-09-28 2018-01-11 Intarcia Therapeutics Inc Instaurazione e/o terminazione rapida di erogazione di farmaci in modo sostanzialmente stazionario
EP2556082B1 (de) 2010-04-08 2017-02-22 Emory University Substituierte androst-4-en-dione
SG188317A1 (en) 2010-08-30 2013-04-30 Sinusys Corp Devices for dilating a paranasal sinus opening and for treating sinusitis
US20120208755A1 (en) 2011-02-16 2012-08-16 Intarcia Therapeutics, Inc. Compositions, Devices and Methods of Use Thereof for the Treatment of Cancers
US9585930B2 (en) 2011-03-20 2017-03-07 Trustees Of Boston University Therapeutic agent for emphysema and COPD
EP2688559B1 (de) * 2011-03-24 2018-05-09 STOCO 10 GmbH Schluckbare medikamentenkapsel
ITFI20110114A1 (it) 2011-05-31 2012-12-01 Scuola Superiore Di Studi Universit Arie Di Perfe Piattaforma robotica per chirurgia mininvasiva
US20140227293A1 (en) 2011-06-30 2014-08-14 Trustees Of Boston University Method for controlling tumor growth, angiogenesis and metastasis using immunoglobulin containing and proline rich receptor-1 (igpr-1)
US20130090633A1 (en) * 2011-10-07 2013-04-11 University Of Southern California Osmotic patch pump
TWI615155B (zh) * 2011-11-01 2018-02-21 拜耳股份有限公司 滲透活性的陰道遞送系統
WO2013130468A1 (en) 2012-02-29 2013-09-06 SinuSys Corporation Devices and methods for dilating a paranasal sinus opening and for treating sinusitis
US9737364B2 (en) 2012-05-14 2017-08-22 Vanderbilt University Local magnetic actuation of surgical devices
WO2013174735A1 (en) 2012-05-21 2013-11-28 Bayer Pharma Aktiengesellschaft Substituted benzothienopyrimidines
US9826904B2 (en) 2012-09-14 2017-11-28 Vanderbilt University System and method for detecting tissue surface properties
US20140081169A1 (en) * 2012-09-17 2014-03-20 Vanderbilt University System and method of tetherless insufflation in colon capsule endoscopy
TW201412740A (zh) 2012-09-20 2014-04-01 Bayer Pharma AG 經取代之吡咯并嘧啶胺基苯并噻唑酮
CN102871982B (zh) 2012-10-16 2014-09-10 中国科学院上海药物研究所 一种药物渗透泵制剂
WO2014113697A1 (en) 2013-01-17 2014-07-24 Vanderbilt University Real-time pose and magnetic force detection for wireless magnetic capsule
US9687263B2 (en) 2013-05-30 2017-06-27 SinuSys Corporation Devices and methods for inserting a sinus dilator
WO2015027146A1 (en) 2013-08-22 2015-02-26 The General Hospital Corporation Inhibitors of human 12/15-lipoxygenase
WO2015191900A1 (en) 2014-06-12 2015-12-17 Ligand Pharmaceuticals, Inc. Glucagon antagonists
WO2016040451A1 (en) 2014-09-09 2016-03-17 Vanderbilt University Hydro-jet endoscopic capsule and methods for gastric cancer screening in low resource settings
US9889085B1 (en) 2014-09-30 2018-02-13 Intarcia Therapeutics, Inc. Therapeutic methods for the treatment of diabetes and related conditions for patients with high baseline HbA1c
US10925639B2 (en) 2015-06-03 2021-02-23 Intarcia Therapeutics, Inc. Implant placement and removal systems
EP3370705B1 (de) 2015-11-05 2022-03-09 The General Hospital Corporation Intrathekale verabreichung von nukleinsäuresequenzen zur codierung von abcd1 zur behandlung von adrenomyeloneuropathie
KR20240037175A (ko) 2016-05-16 2024-03-21 인타르시아 세라퓨틱스 인코포레이티드 글루카곤-수용체 선택적 폴리펩티드 및 이들의 이용 방법
USD840030S1 (en) 2016-06-02 2019-02-05 Intarcia Therapeutics, Inc. Implant placement guide
USD860451S1 (en) 2016-06-02 2019-09-17 Intarcia Therapeutics, Inc. Implant removal tool
AU2017345724B2 (en) 2016-10-20 2024-04-18 Peptron, Inc. Methods of delivering a neuroprotective polypeptide to the central nervous system
MX2019008006A (es) 2017-01-03 2019-08-29 Intarcia Therapeutics Inc Metodos que comprenden la administracion continua de un agonista del receptor de glp-1 y la co-administracion de un farmaco.
EP3592376A1 (de) 2017-03-08 2020-01-15 Intarcia Therapeutics, Inc Vorrichtung und verfahren zur verabreichung einer nauseogenen verbindung aus einer arzneimittelabgabevorrichtung
US11122965B2 (en) 2017-10-09 2021-09-21 Vanderbilt University Robotic capsule system with magnetic actuation and localization
EP3752249A1 (de) 2018-02-13 2020-12-23 Ligand Pharmaceuticals, Inc. Glucagonrezeptorantagonisten
USD933219S1 (en) 2018-07-13 2021-10-12 Intarcia Therapeutics, Inc. Implant removal tool and assembly
CN113195524A (zh) 2018-10-11 2021-07-30 因塔西亚治疗公司 人类胰淀素类似物多肽和使用方法
US20200155466A1 (en) * 2018-11-21 2020-05-21 II Don S. Houtz Oral Medicine Delivery Capsule
CN109589491B (zh) * 2019-01-29 2024-01-09 上海安翰医疗技术有限公司 自动给药装置
BR112022013784A2 (pt) 2020-01-13 2022-10-11 Durect Corp Sistemas de distribuição de fármacos de liberação prolongada com impurezas reduzidas e métodos relacionados
CA3203561A1 (en) 2021-01-12 2022-07-21 Adrian Neil Verity Sustained release drug delivery systems and related methods
WO2025160155A1 (en) 2024-01-22 2025-07-31 The Broad Institute, Inc. Epigenetic targeting of prion diseases
WO2025194118A1 (en) 2024-03-15 2025-09-18 Children's Hospital Medical Center Formulations and methods for alleviating sleep disorders

Family Cites Families (29)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3732865A (en) 1971-01-13 1973-05-15 Alza Corp Osmotic dispenser
US3995631A (en) 1971-01-13 1976-12-07 Alza Corporation Osmotic dispenser with means for dispensing active agent responsive to osmotic gradient
US3845770A (en) 1972-06-05 1974-11-05 Alza Corp Osmatic dispensing device for releasing beneficial agent
US3929132A (en) * 1973-04-10 1975-12-30 Alza Corp Osmotic dispenser
US3995632A (en) 1973-05-04 1976-12-07 Alza Corporation Osmotic dispenser
US3916889A (en) 1973-09-28 1975-11-04 Sandoz Ag Patient ventilator apparatus
US3888249A (en) * 1973-11-02 1975-06-10 David L Spencer Arterial infusion catheter
US4111203A (en) 1976-11-22 1978-09-05 Alza Corporation Osmotic system with means for improving delivery kinetics of system
US4203439A (en) 1976-11-22 1980-05-20 Alza Corporation Osmotic system with volume amplifier for increasing amount of agent delivered therefrom
US4111202A (en) 1976-11-22 1978-09-05 Alza Corporation Osmotic system for the controlled and delivery of agent over time
US4243030A (en) 1978-08-18 1981-01-06 Massachusetts Institute Of Technology Implantable programmed microinfusion apparatus
US4373527B1 (en) 1979-04-27 1995-06-27 Univ Johns Hopkins Implantable programmable medication infusion system
US4340054A (en) 1980-12-29 1982-07-20 Alza Corporation Dispenser for delivering fluids and solids
US4439196A (en) 1982-03-18 1984-03-27 Merck & Co., Inc. Osmotic drug delivery system
US4552561A (en) 1982-12-23 1985-11-12 Alza Corporation Body mounted pump housing and pump assembly employing the same
US4639244A (en) 1983-05-03 1987-01-27 Nabil I. Rizk Implantable electrophoretic pump for ionic drugs and associated methods
US4865845A (en) 1986-03-21 1989-09-12 Alza Corporation Release rate adjustment of osmotic or diffusional delivery devices
US4874388A (en) 1987-06-25 1989-10-17 Alza Corporation Multi-layer delivery system
US5151093A (en) 1990-10-29 1992-09-29 Alza Corporation Osmotically driven syringe with programmable agent delivery
GB9027422D0 (en) 1990-12-18 1991-02-06 Scras Osmotically driven infusion device
US5137727A (en) 1991-06-12 1992-08-11 Alza Corporation Delivery device providing beneficial agent stability
US5223265A (en) 1992-01-10 1993-06-29 Alza Corporation Osmotic device with delayed activation of drug delivery
US5308348A (en) 1992-02-18 1994-05-03 Alza Corporation Delivery devices with pulsatile effect
US5456679A (en) 1992-02-18 1995-10-10 Alza Corporation Delivery devices with pulsatile effect
US5980508A (en) * 1994-06-22 1999-11-09 Controlled Release Technologies Pty Ltd Controlled release device and method
US5731001A (en) * 1995-06-07 1998-03-24 Magruder; Judy A. Locking couplings for osmotic delivery devices
EP1238659B1 (de) 1996-02-02 2004-09-29 ALZA Corporation Implantierbares System mit verzögerter Wirkstofffreisetzung
JP4173635B2 (ja) * 1997-12-29 2008-10-29 インターシア セラピューティクス，インコーポレイティド 膜プラグ保持機構を有する浸透供給装置
ZA986627B (en) * 1997-12-30 1999-03-05 Alza Corp Beneficial agent delivery system with membrane plug and method for controlling delivery of beneficial agents

Also Published As

Publication number Publication date
US20010022974A1 (en) 2001-09-20
DE69822208D1 (de) 2004-04-08
US6976981B2 (en) 2005-12-20
ES2217613T3 (es) 2004-11-01
US20010021822A1 (en) 2001-09-13
AU1828599A (en) 1999-07-19
CA2316976A1 (en) 1999-07-08
JP2001526939A (ja) 2001-12-25
US20050048097A1 (en) 2005-03-03
DE69822208T2 (de) 2005-04-28
WO1999033446A1 (en) 1999-07-08
CA2316976C (en) 2009-02-17
US6270787B1 (en) 2001-08-07
US6899887B2 (en) 2005-05-31
TW446552B (en) 2001-07-21
US20040243106A1 (en) 2004-12-02
EP1041968A1 (de) 2000-10-11
HK1031332A1 (en) 2001-06-15
ZA9811880B (en) 1999-06-29
EP1041968B1 (de) 2004-03-03
JP4173635B2 (ja) 2008-10-29
AR014194A1 (es) 2001-02-07

Similar Documents

Publication Publication Date Title
ATE260640T1 (de) Osmotisches verabreichungssystem mit stöpselrückhaltemechanismus
ATE357911T1 (de) Osmotisches verabreichungssystem mit semipermeablem stöpsel
FI973024A7 (fi) Yhdisteitä, joilla on vaikutuksia serotoniiniin liittyviin järjestelmi in
ATE486589T1 (de) Osmotische dosierungsform mit verlängerter wirkstoffabgabe
ATE259409T1 (de) Abgabesystem mit ablösesperrschicht beladenen zeolite
DK1030817T3 (da) Brændstofdispenseringssystem
DE69803414D1 (de) Steckverbinder mit Verriegelungshebel
DE69724846D1 (de) Mehrweg-Ein/Ausgabespeichersysteme mit Mehrweg-Ein/Ausgabeanforderungsmechanismus
DE69617881D1 (de) Steckverbinder mit Verriegelungshebel
NO20003154D0 (no) Stikkplugg
DE59604114D1 (de) Kautablette mit brausewirkung
DE122004000002I1 (de) Diclofenac-Natrium-Pflaster.
DE69518960D1 (de) Verbinder mit Verriegelungsvorrichtung
DE69703682D1 (de) Hebelartiger Steckverbinder
DE69706760D1 (de) Schnürband mit Verbinder
DE59801536D1 (de) Tanksystem
BR9700881A (pt) Sistema de retenção de pino transportador usando aberturas de deslocamento
DE69722867D1 (de) Hebelartiger Steckverbinder
DE69828470D1 (de) Verbinder mit Kontaktverriegelung
DE69800463D1 (de) Hebelartiger Steckverbinder
DE69800802D1 (de) Optisches system mit unbeschraenkter schaerfentiefe
DE69617810D1 (de) Verbinder mit rotierbarem Verriegelungsmechanismus
NL1006015A1 (nl) Toedieninrichting.
DE69811022D1 (de) Verbinder mit Verriegelungsglied
DE69705550D1 (de) Steckverbinder mit Verriegelungshebel

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties